| Gene symbol | CSH1 | Synonyms | CS-1, CSA, CSMT, GHB3, PL, hCS-1, hCS-A | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | |
| Description | chorionic somatomammotropin hormone 1 | ||||
| GTO ID | GTC1076 |
| Trial ID | ChiCTR-OPC-17014095 |
| Disease | Hematologic Cancer |
| Altered gene | CS1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CS1 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Validity and security of leveraging CS1 chimeric antigen receptor T-cell therapy treating relapsed/ refractory/ high risk CS1+ hematological malignancy: a single-center, open, single-arm clinical study |
| Year | 2017 |
| Country | China |
| Company sponsor | Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||